1. Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid–dependent asthma in Sweden. (2nd August 2020) Authors: Andersson, Maria; Janson, Christer; Kristensen, Thomas; Szende, Agota; Golam, Sarowar Journal: Journal of medical economics Issue: Volume 23:Number 8(2020) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗